On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Around 50% of patients admitted to intensive care units (ICUs) develop an acquired innate immune dysfunction related to the severity of their underlying presentation. This increases the risk of secondary infection in the ICU, which drives pressures to prescribe antibiotics, which in turn encourages the emergence of antimicrobial resistance.
The talk will primarily consider potential mechanisms underlying the critical illness-induced dysfunction in neutrophils and how these suggest therapeutic targets, finishing with a description of clinical trials we are about to start, ultimately seeking to translate our work into a non-antibiotic-based strategy for reducing ICU-acquired infection.
